<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Mebutamate</id>
	<title>Mebutamate - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Mebutamate"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Mebutamate&amp;action=history"/>
	<updated>2026-04-26T05:23:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Mebutamate&amp;diff=5368534&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Mebutamate&amp;diff=5368534&amp;oldid=prev"/>
		<updated>2024-03-06T04:06:25Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Mebutamate.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Mebutamate&amp;#039;&amp;#039;&amp;#039; is a [[carbamate]] derivative used as an [[anxiolytic]] drug. It is similar in structure and function to [[barbiturates]] and is generally considered part of the group of sedative-hypnotic drugs. Mebutamate is primarily used to treat short-term [[anxiety]] and tension, and it is marketed under the brand names &amp;#039;&amp;#039;Equanil&amp;#039;&amp;#039; and &amp;#039;&amp;#039;Miltown&amp;#039;&amp;#039;.&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
&lt;br /&gt;
Mebutamate was first synthesized in the 1950s and quickly gained popularity as a treatment for anxiety and tension. It was one of the first drugs of its kind, predating the development of [[benzodiazepines]], which are now more commonly used for these purposes.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
Mebutamate acts on the [[GABA receptor]], enhancing the effect of the neurotransmitter [[GABA]] in the brain. This results in a calming effect, reducing feelings of anxiety and tension. The drug is rapidly absorbed in the gastrointestinal tract and is metabolized in the liver.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
&lt;br /&gt;
Common side effects of mebutamate include drowsiness, dizziness, and weakness. More serious side effects can include confusion, slow heart rate, and difficulty breathing. Long-term use of mebutamate can lead to [[physical dependence]] and withdrawal symptoms if the drug is abruptly discontinued.&lt;br /&gt;
&lt;br /&gt;
== Legal Status ==&lt;br /&gt;
&lt;br /&gt;
In the United States, mebutamate is classified as a Schedule IV controlled substance under the [[Controlled Substances Act]]. This means it has a low potential for abuse and low risk of dependence.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
&lt;br /&gt;
* [[Carbamates]]&lt;br /&gt;
* [[Anxiolytic]]&lt;br /&gt;
* [[GABA receptor]]&lt;br /&gt;
* [[Controlled Substances Act]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Anxiolytics]]&lt;br /&gt;
[[Category:Carbamates]]&lt;br /&gt;
{{pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>